Cencora Management
Management criteria checks 1/4
Cencora's CEO is Bob Mauch, appointed in Oct 2024, has a tenure of 1.08 years. total yearly compensation is $9.25M, comprised of 11.2% salary and 88.8% bonuses, including company stock and options. directly owns 0.035% of the company’s shares, worth $24.26M. The average tenure of the management team and the board of directors is 1.1 years and 2.5 years respectively.
Key information
Bob Mauch
Chief executive officer
US$9.3m
Total compensation
| CEO salary percentage | 11.24% |
| CEO tenure | 1.1yrs |
| CEO ownership | 0.03% |
| Management average tenure | 1.1yrs |
| Board average tenure | 2.5yrs |
Recent management updates
Recent updates
Cencora, Inc. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next
Aug 09
Cencora Q3: Growing Specialty Drug Distributions, Initiate At Buy
Aug 08Why We're Not Concerned About Cencora, Inc.'s (NYSE:COR) Share Price
Apr 07Cencora: Great Track Record And Outlook, But Valuation Does Not Offer Upside
Feb 25Is Cencora (NYSE:COR) Using Too Much Debt?
Jan 27Cencora's (NYSE:COR) Soft Earnings Are Actually Better Than They Appear
Dec 05Cencora: Credentials To Die For, But Underlying Issues Make Case For 'Hold' Rating
Sep 18Cencora: Potential Exists, But Ambiguous Valuations And Data Breach Risks Are Concerning
Jun 30Cencora Remains Chronically Undervalued, With Material Growth Potential
Mar 25CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2025 | n/a | n/a | US$2b |
| Jun 30 2025 | n/a | n/a | US$2b |
| Mar 31 2025 | n/a | n/a | US$2b |
| Dec 31 2024 | n/a | n/a | US$1b |
| Sep 30 2024 | US$9m | US$1m | US$2b |
| Jun 30 2024 | n/a | n/a | US$2b |
| Mar 31 2024 | n/a | n/a | US$2b |
| Dec 31 2023 | n/a | n/a | US$2b |
| Sep 30 2023 | US$8m | US$975k | US$2b |
| Jun 30 2023 | n/a | n/a | US$2b |
| Mar 31 2023 | n/a | n/a | US$2b |
| Dec 31 2022 | n/a | n/a | US$2b |
| Sep 30 2022 | US$6m | US$850k | US$2b |
| Jun 30 2022 | n/a | n/a | US$2b |
| Mar 31 2022 | n/a | n/a | US$2b |
| Dec 31 2021 | n/a | n/a | US$2b |
| Sep 30 2021 | US$6m | US$800k | US$2b |
| Jun 30 2021 | n/a | n/a | -US$4b |
| Mar 31 2021 | n/a | n/a | -US$4b |
| Dec 31 2020 | n/a | n/a | -US$3b |
| Sep 30 2020 | US$4m | US$700k | -US$3b |
| Jun 30 2020 | n/a | n/a | US$2b |
| Mar 31 2020 | n/a | n/a | US$2b |
| Dec 31 2019 | n/a | n/a | US$649m |
| Sep 30 2019 | US$4m | US$675k | US$855m |
Compensation vs Market: Bob's total compensation ($USD9.25M) is below average for companies of similar size in the US market ($USD13.59M).
Compensation vs Earnings: Bob's compensation has increased by more than 20% in the past year.
CEO
Bob Mauch (58 yo)
Dr. Robert P. Mauch, PharmD, Ph D., also known as Bob, served as an Executive Vice President at Cencora, Inc. (formerly known as AmerisourceBergen Corporation) since February 2015 until September 2024 and...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 1.1yrs | US$9.25m | 0.035% $ 24.3m | |
| Executive VP & CFO | 7yrs | US$9.00m | 0.069% $ 48.4m | |
| Executive VP & Chief Legal Officer | 4.2yrs | US$7.67m | 0.014% $ 9.5m | |
| Executive VP & Chief Human Resources Officer | 6.8yrs | US$5.32m | 0.010% $ 7.2m | |
| Senior VP | 13.8yrs | no data | 0.011% $ 7.4m | |
| Executive VP and Chief Data & Information Officer | 1.1yrs | no data | 0.0022% $ 1.5m | |
| Senior VP | no data | no data | no data | |
| Senior VP & Chief Compliance Officer | no data | no data | no data | |
| EVP and President of U.S. Pharmaceuticals & Animal Health | 1.1yrs | no data | no data | |
| EVP & President of International Business Group | 1.1yrs | no data | no data | |
| Executive VP and Chief Strategy and M&A Officer | 1yr | no data | no data | |
| Senior VP | no data | no data | no data |
Experienced Management: COR's management team is not considered experienced ( 1.1 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 1.1yrs | US$9.25m | 0.035% $ 24.3m | |
| Independent Director | 2.1yrs | US$428.13k | 0.00022% $ 154.3k | |
| Independent Chairman of the Board | 10.2yrs | US$375.02k | 0.010% $ 7.1m | |
| Independent Director | 12.5yrs | US$322.66k | 0.0077% $ 5.4m | |
| Independent Director | 5.8yrs | US$375.39k | 0.0065% $ 4.6m | |
| Independent Director | less than a year | no data | no data | |
| Independent Director | 2.1yrs | US$435.63k | no data | |
| Independent director | 3.1yrs | US$320.16k | 0.000090% $ 63.1k | |
| Independent Director | 2.8yrs | US$351.46k | 0.00081% $ 567.9k | |
| Independent Director | 1.1yrs | no data | no data |
Experienced Board: COR's board of directors are not considered experienced ( 2.5 years average tenure), which suggests a new board.
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/11/19 12:29 |
| End of Day Share Price | 2025/11/19 00:00 |
| Earnings | 2025/09/30 |
| Annual Earnings | 2025/09/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Cencora, Inc. is covered by 30 analysts. 14 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| David Toung | Argus Research Company |
| Eric Coldwell | Baird |
| Allen Lutz | BofA Global Research |